C07K 14/655
Somatostatins
C07K14/655 (Somatostatins) appears on 409 US grants and 223 published applications in this corpus.
Search patents in C07K- Granted patents
- 409
- Published applications
- 223
- Assignees
- 171
- Inventors
- 610
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 11 | 0 |
| 1978 | 20 | 0 |
| 1979 | 10 | 0 |
| 1980 | 20 | 0 |
| 1981 | 6 | 0 |
| 1982 | 11 | 0 |
| 1983 | 5 | 0 |
| 1984 | 11 | 0 |
| 1985 | 6 | 0 |
| 1986 | 6 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 7 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 1 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 13 | 0 |
| 1998 | 35 | 0 |
| 1999 | 24 | 0 |
| 2000 | 8 | 0 |
| 2001 | 13 | 2 |
| 2002 | 11 | 8 |
| 2003 | 6 | 10 |
| 2004 | 6 | 14 |
| 2005 | 6 | 9 |
| 2006 | 12 | 12 |
| 2007 | 8 | 9 |
| 2008 | 3 | 19 |
| 2009 | 10 | 13 |
| 2010 | 5 | 10 |
| 2011 | 7 | 9 |
| 2012 | 6 | 12 |
| 2013 | 13 | 9 |
| 2014 | 7 | 11 |
| 2015 | 14 | 10 |
| 2016 | 8 | 12 |
| 2017 | 4 | 11 |
| 2018 | 6 | 6 |
| 2019 | 5 | 7 |
| 2020 | 4 | 8 |
| 2021 | 4 | 4 |
| 2022 | 6 | 6 |
| 2023 | 1 | 1 |
| 2024 | 1 | 2 |
| 2025 | 3 | 5 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging13 May 2025US 12,297,157 B2Cornell University
- Cortistatin analogues for the treatment of inflammatory and/or immune diseases13 May 2025US 12,297,294 B2Bcn Peptides, S.A.
- GBD-SSTad-SSTad recombinant protein and method for producing and using same21 Jan 2025US 12,202,875 B2Limited Liability Company “Urspharm”
- Peptide analogs8 Oct 2024US 12,110,318 B2Adepthera LLC
- Synthetic somatostatin receptor ligands28 Nov 2023US 11,827,687 B2Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Dual receptor targeting radioligands and uses thereof related applications27 Aug 2026US 2026/0248972 A1Full-Life Technologies HK Limited
- Halogenated somatostatin analogs with multiple somatostatin receptor subtype selectivity26 Feb 2026US 2026/0053958 A1Grafton Therapeutics SàRl
- Dimeric radiopharmaceuticals, compositions thereof and uses thereof26 Feb 2026US 2026/0053960 A1Clarity Pharmaceuticals Ltd
- Method for Synthesizing Amide and/or Polypeptide Using Temporary Protected Amino Acid as Ammonia Component1 Jan 2026US 2026/0001906 A1Guangzhou Medical University
- 18f-labeled peptide ligands useful in pet and cerenkov luminescene imaging25 Dec 2025US 2025/0388523 A1Cornell University
Most cited
By later US patents
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier238US 4,801,575 AThe Regents of the University of California · 1989
- Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases229US 5,759,542 ANew England Deaconess Hospital Corporation · 1998
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier215US 4,902,505 AAlkermes, Inc. · 1990
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Tumor-targeted optical contrast agents142US 7,198,778 B2Mallinckrodt Inc. · 2007